Year: 2021
Type: editorial
Abstract: Cervical cancer prevention and control is quickly evolving.Basic scientists, epidemiologists, clinician insight, health communication scientists, women's and gender studies scientists, public health scientists, engineers, implementation scientists and industrial science all contribute to the understanding of the multiple inputs that are necessary to have a patient-centered efficient program reducing cervical cancer.Unlike more focused groups, the World Health Organization (WHO) promotes a comprehensive program to realize this potential.1 The vaccination, screening and treatment goals remain the same, but the specifics of each continue to evolve.Starting with HPV vaccination, we have now seen that three doses shrink to only one necessary HPV dose 2 to protect girls from persistent HPV infection that lasts through womanhood to the age of onset of screening.One dose provides efficiency in vaccine delivery and less burden on registries for timely follow up doses.Regardless of number of doses, vaccination remains the first step of this process and requires uptake to be successful.
Source: International Journal of Cancer
DOI: 10.1002/ijc.33851
Authors: Diane M. Harper, Laura S. Rozek
Institutions: University of Michigan, U-M Rogel Cancer Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3206681548